TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways
British Journal of Dermatology · 17.07.2023 · 189 (2) · 195-209
DOI: 10.1093/bjd/ljad078 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 17.03.2023. Verfasst von Jie Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology of First Affiliated Hospital, and Institute of Dermatology. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Membrane Proteins. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Project of Natural Science Research in Colleges, Universities in Anhui Province.
Abstract (Originalsprache)
Background
Our group previously found that the transmembrane protein 232 (TMEM232) gene was associated with atopic dermatitis (AD) by genome-wide association study and fine mapping study. However, its function is unclear so far.
Objectives
To investigate the roles and mechanisms of TMEM232 in AD.
Methods
The expression of TMEM232 was investigated in skin lesions of patients with AD, the MC903-induced AD mouse model, human primary keratinocytes and immortalized human keratinocyte cell line (HaCaT) cells stimulated with different inflammatory factors. The role of TMEM232 in AD was analysed in HaCaT cells and Tmem232 knockout (Tmem232–/–) mice. Tmem232-specific small interfering RNA (siRNA) was used to evaluate its therapeutic potential in the AD mouse model.
Results
The expression of TMEM232 was significantly increased in skin lesions of patients with AD, the MC903-induced AD mouse model and human primary keratinocytes and HaCaT cells stimulated with different inflammatory factors compared with controls. In the presence of MC903, Tmem232–/– mice exhibited significantly reduced dermatitis severity, mast-cell infiltration in the back, and expression of T-helper (Th)1 and Th2-related inflammatory factors in skin tissue compared with wild-type mice. In vitro and in vivo experiments further showed that upregulation of TMEM232 in AD exacerbated the inflammation response through activating the pathway of nuclear factor-κB and signal transducer and activator of transcription (STAT) 3, and was regulated by the interleukin-4/STAT6 axis, which formed a self-amplifying loop. Finally, topical application of Tmem232 siRNA markedly ameliorated AD-like lesions in the AD model.
Conclusions
This study is the first to outline the function of TMEM232. It is involved in regulating inflammation in AD and may be a potential target for AD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology of First Affiliated Hospital, and Institute of Dermatology.
- Key Laboratory of Dermatology (Ministry of Education).
- School of Biomedical Engineering, Research and Engineering Center of Biomedical Materials, Anhui Provincial Institute of Translational Medicine.
- The Center for Scientific Research of Anhui Medical University, Hefei, Anhui, China.
- Anhui Medical University, Hefei, Anhui, China.
- Laboratory of Inflammatory and Immune Diseases, Hefei, Anhui, China.
ORCID-Profile: Fengli Xiao
Förderung
- National Natural Science Foundation of China
- Key Project of Natural Science Research in Colleges
- Universities in Anhui Province
- Scientific Research Activities of Academic
- Technological Leaders of Anhui Province
- Natural Science Foundation of Anhui Province
- Anhui Medical University
Zitieren
APA
Han, J., Cai, X., Qin, S., Zhang, Z., Wu, Y., Shi, Y., Deng, T., Chen, B., Liu, L., Qian, H., Fang, W., & Xiao, F. (2023). TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways. British Journal of Dermatology, 189(2), 195-209. https://doi.org/10.1093/bjd/ljad078
Vancouver
Han J, Cai X, Qin S, Zhang Z, Wu Y, Shi Y, et al. TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways. British Journal of Dermatology. 2023;189(2):195-209. doi:10.1093/bjd/ljad078
BibTeX
@article{Han2023,
author = {Han, Jie and Cai, Xinying and Qin, Shichun and Zhang, Zengyunou and Wu, Yuanyuan and Shi, Yuanzhe and Deng, Tingyue and Chen, Benjin and Liu, Li and Qian, Haisheng and Fang, Wenliang and Xiao, Fengli},
title = {TMEM232 promotes the inflammatory response in atopic dermatitis via the nuclear factor-κB and signal transducer and activator of transcription 3 signalling pathways},
journal = {British Journal of Dermatology},
year = {2023},
volume = {189},
number = {2},
pages = {195--209},
doi = {10.1093/bjd/ljad078}
}
EUVIMED